tiprankstipranks
BioStem Technologies (BSEM)
OTHER OTC:BSEM
US Market

BioStem Technologies (BSEM) Financial Statements

275 Followers

BioStem Technologies Financial Overview

BioStem Technologies's market cap is currently $84.96M. The company's EPS TTM is $-0.67; its P/E ratio is -9.69; BioStem Technologies is scheduled to report earnings on March 24, 2026, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Mar 25Mar 24Mar 23Mar 22
Income Statement
Total Revenue$ 47.48M$ 301.83M$ 16.69M$ 6.88M$ 4.34M
Gross Profit$ 44.22M$ 287.86M$ 15.42M$ 5.99M$ 2.87M
Operating Income$ -689.15K$ 31.20M$ -7.78M$ -4.68M$ -1.61M
EBITDA$ -469.73K$ 31.49M$ -7.55M$ -6.52M$ -602.00K
Net Income$ -6.58M$ 31.88M$ -8.48M$ -7.07M$ -1.45M
Balance Sheet
Cash & Short-Term Investments$ 29.55M$ 22.83M$ 239.41K$ 772.14K$ 340.33K
Total Assets$ 50.03M$ 140.55M$ 14.56M$ 3.47M$ 2.67M
Total Debt$ 3.33M$ 4.50M$ 4.77M$ 5.21M$ 4.83M
Net Debt$ -26.22M$ -18.33M$ 4.53M$ 4.32M$ 4.49M
Total Liabilities$ 10.89M$ 99.67M$ 15.90M$ 7.42M$ 8.47M
Stockholders' Equity$ 39.14M$ 40.88M$ -1.34M$ -4.08M$ -5.96M
Cash Flow
Free Cash Flow$ 6.59M$ 24.05M$ -3.60M$ -2.11M$ -152.29K
Operating Cash Flow$ 9.94M$ 24.48M$ -3.50M$ -1.64M$ -109.44K
Investing Cash Flow$ -2.10M$ -1.68M$ -210.33K$ -469.48K$ -7.85K
Financing Cash Flow$ -1.12M$ -206.78K$ 3.18M$ 597.71K$ 357.42K
Currency in USD

BioStem Technologies Earnings and Revenue History

BioStem Technologies Debt to Assets

BioStem Technologies Cash Flow

BioStem Technologies Forecast EPS vs Actual EPS